Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
- Autores
- Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.
- Año de publicación
- 2007
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society.
Fil: Piotrkowski, Barbara. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Fraga, Cesar G.. Universidad de Buenos Aires; Argentina. University of California at Davis; Estados Unidos
Fil: De Cavanagh, Elena M. V.. Universidad de Buenos Aires; Argentina - Materia
-
Angiotensin
Membrane Potential
Uncoupling Protein
N-Nitro-L-Arginine Methyl Esther
Reactive Oxygen Species - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/63046
Ver los metadatos del registro completo
id |
CONICETDig_85abb7f45332b586dab99fc10ab43d39 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/63046 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidneyPiotrkowski, BarbaraFraga, Cesar G.De Cavanagh, Elena M. V.AngiotensinMembrane PotentialUncoupling ProteinN-Nitro-L-Arginine Methyl EstherReactive Oxygen Specieshttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society.Fil: Piotrkowski, Barbara. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Fraga, Cesar G.. Universidad de Buenos Aires; Argentina. University of California at Davis; Estados UnidosFil: De Cavanagh, Elena M. V.. Universidad de Buenos Aires; ArgentinaAmerican Physiological Society2007-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/63046Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.; Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney; American Physiological Society; American Journal Of Physiology-regulatory, Integrative And Comparative Physiology; 292; 4; 4-2007; 1494-15010363-6119CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.physiology.org/doi/full/10.1152/ajpregu.00540.2006info:eu-repo/semantics/altIdentifier/doi/10.1152/ajpregu.00540.2006info:eu-repo/semantics/altIdentifier/pmid/17185409info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:34:12Zoai:ri.conicet.gov.ar:11336/63046instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:34:12.319CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney |
title |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney |
spellingShingle |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney Piotrkowski, Barbara Angiotensin Membrane Potential Uncoupling Protein N-Nitro-L-Arginine Methyl Esther Reactive Oxygen Species |
title_short |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney |
title_full |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney |
title_fullStr |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney |
title_full_unstemmed |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney |
title_sort |
Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney |
dc.creator.none.fl_str_mv |
Piotrkowski, Barbara Fraga, Cesar G. De Cavanagh, Elena M. V. |
author |
Piotrkowski, Barbara |
author_facet |
Piotrkowski, Barbara Fraga, Cesar G. De Cavanagh, Elena M. V. |
author_role |
author |
author2 |
Fraga, Cesar G. De Cavanagh, Elena M. V. |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Angiotensin Membrane Potential Uncoupling Protein N-Nitro-L-Arginine Methyl Esther Reactive Oxygen Species |
topic |
Angiotensin Membrane Potential Uncoupling Protein N-Nitro-L-Arginine Methyl Esther Reactive Oxygen Species |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society. Fil: Piotrkowski, Barbara. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Fraga, Cesar G.. Universidad de Buenos Aires; Argentina. University of California at Davis; Estados Unidos Fil: De Cavanagh, Elena M. V.. Universidad de Buenos Aires; Argentina |
description |
The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society. |
publishDate |
2007 |
dc.date.none.fl_str_mv |
2007-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/63046 Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.; Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney; American Physiological Society; American Journal Of Physiology-regulatory, Integrative And Comparative Physiology; 292; 4; 4-2007; 1494-1501 0363-6119 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/63046 |
identifier_str_mv |
Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.; Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney; American Physiological Society; American Journal Of Physiology-regulatory, Integrative And Comparative Physiology; 292; 4; 4-2007; 1494-1501 0363-6119 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.physiology.org/doi/full/10.1152/ajpregu.00540.2006 info:eu-repo/semantics/altIdentifier/doi/10.1152/ajpregu.00540.2006 info:eu-repo/semantics/altIdentifier/pmid/17185409 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Physiological Society |
publisher.none.fl_str_mv |
American Physiological Society |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614358119743488 |
score |
13.070432 |